Ideas
Overweight U.S. large caps on earnings
Earnings have driven equities higher this year, not multiple expansion, and fundamentals remain strong. Solid reporting is expected, and worries around geopolitics, inflation, and AI sustainability will fade. Investors should stay fully allocated to equities, overweight U.S. large caps, and add on pullbacks.
Stay short duration, avoid long bonds
Yields are expected to stay elevated, and the long end of the curve could creep toward 5%. Bonds have not provided the historical diversification benefit during shocks. The portfolio is very short duration, and there is very little reason to add duration near term.
Stay short duration, avoid long bonds
Yields are expected to stay elevated, and the long end of the curve could creep toward 5%. Bonds have not provided the historical diversification benefit during shocks. The portfolio is very short duration, and there is very little reason to add duration near term.
Avoid corporate credit, favor equities
Credit spreads are extremely tight, trading near 15-year tights, and do not reflect the same concerns that equities have priced. Risk is better taken in equities; prefer equities over corporate credit.
Watch memory chipmakers for China disruption
Chinese memory maker CXMT's potential qualification by Apple could disrupt the DRAM oligopoly, hurting the cash flows and pricing power of incumbent memory manufacturers. This is a huge risk for the memory complex.
Energy prices face prolonged upward pressure
Even in a diplomatic off-ramp scenario, damaged pipelines, refineries and infrastructure will take time to come back online, causing a prolonged period of upward pressure on energy prices. This will keep the Federal Reserve hawkish.
Natural gas is next AI currency
Natural gas is set to become the next currency of AI as massive data center buildouts require reliable power generation. This creates a structural demand driver and makes natural gas a key investment focus.
H.B. Fuller medical adhesive strategy creates value
The company is executing its strategic plan to move into high-margin medical adhesives via the AMS acquisition. Despite activist pushback, management believes this will drive the best value for shareholders and has already improved EBITDA margins by 400 basis points.
This Bloomberg Markets video, published July 27, 2026,
features Kate Moore, Mandeep Singh, Kelly Covley, Akhil Bansal, Celeste Mastin
discussing SPY, SHV, TLT, LQD, MU, 000660.KS, WTI, UNG, FUL.
8 trade ideas extracted by AI with direction and confidence scoring.
Speakers:
Kate Moore,
Mandeep Singh,
Kelly Covley,
Akhil Bansal,
Celeste Mastin
· Tickers:
SPY,
SHV,
TLT,
LQD,
MU,
000660.KS,
WTI,
UNG,
FUL